These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31693073)

  • 1. Ranking Antipsychotics for Efficacy and Safety in Schizophrenia.
    Correll CU; Kane JM
    JAMA Psychiatry; 2020 Mar; 77(3):225-226. PubMed ID: 31693073
    [No Abstract]   [Full Text] [Related]  

  • 2. Selecting antipsychotics in schizophrenia: lessons from CATIE.
    Haddad P; Dursun SM
    J Psychopharmacol; 2006 May; 20(3):332-4. PubMed ID: 16574710
    [No Abstract]   [Full Text] [Related]  

  • 3. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
    Dold M; Samara MT; Li C; Tardy M; Leucht S
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of polypharmacy using low-dose second-generation antipsychotics plus low-dose first-generation antipsychotics with monotherapy using therapeutic-dose second-generation antipsychotics in schizophrenia - a pooled analysis.
    Lin CH; Wang FC; Huang YH; Lin SC; Kuo CC
    CNS Spectr; 2019 Dec; 24(6):632-633. PubMed ID: 31084636
    [No Abstract]   [Full Text] [Related]  

  • 5. Antipsychotics in adolescent-onset psychosis: a work in progress.
    James AC; Broome MR
    Lancet Psychiatry; 2017 Aug; 4(8):e16-e17. PubMed ID: 28748801
    [No Abstract]   [Full Text] [Related]  

  • 6. Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach.
    Glick ID; Correll CU; Altamura AC; Marder SR; Csernansky JG; Weiden PJ; Leucht S; Davis JM
    J Clin Psychiatry; 2011 Dec; 72(12):1616-27. PubMed ID: 22244023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antipsychotic drug combinations in the treatment of schizophrenia. A review of the literature].
    Gazdag G; Tolna J; Bitter I
    Neuropsychopharmacol Hung; 2012 Sep; 14(3):189-95. PubMed ID: 22987732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders?
    Motlová L; Spaniel F; Höschl C; Balon R
    Ann Clin Psychiatry; 2007; 19(2):133-43. PubMed ID: 17612853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.
    Tandon R; Belmaker RH; Gattaz WF; Lopez-Ibor JJ; Okasha A; Singh B; Stein DJ; Olie JP; Fleischhacker WW; Moeller HJ;
    Schizophr Res; 2008 Mar; 100(1-3):20-38. PubMed ID: 18243663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia.
    Nasrallah HA; Tandon R
    J Clin Psychiatry; 2002; 63 Suppl 13():12-20. PubMed ID: 12562142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of paliperidone ER and other oral atypical antipsychotics in schizophrenia.
    Jones MP; Nicholl D; Trakas K
    Int J Clin Pharmacol Ther; 2010 Jun; 48(6):383-99. PubMed ID: 20497747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer antipsychotics similar to older agents.
    J Fam Pract; 2005 Dec; 54(12):1026. PubMed ID: 16370079
    [No Abstract]   [Full Text] [Related]  

  • 14. First- and second-generation antipsychotics: learning from CUtLASS and CATIE.
    Tandon R; Carpenter WT; Davis JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):977-8; author reply 979-80. PubMed ID: 17679642
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reaction on 'typical and atypical antipsychotics: is there a difference in their influence on neurocognition?'].
    van Oeffelt T
    Tijdschr Psychiatr; 2011; 53(4):255-6; author reply 256-7. PubMed ID: 21506082
    [No Abstract]   [Full Text] [Related]  

  • 16. Lumateperone (Caplyta) for schizophrenia.
    Med Lett Drugs Ther; 2020 Jul; 62(1603):113-116. PubMed ID: 32728011
    [No Abstract]   [Full Text] [Related]  

  • 17. Risperidone: efficacy and safety.
    Umbricht D; Kane JM
    Schizophr Bull; 1995; 21(4):593-606. PubMed ID: 8749887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of schizophrenia negative and positive symptoms with amantadine as add-on therapy to antipsychotics: a case series.
    Gama CS; Lucena DD; Cruz C; Lobato MI; Belmonte-de-Abreu PS
    Braz J Psychiatry; 2010 Jun; 32(2):193-4. PubMed ID: 20658059
    [No Abstract]   [Full Text] [Related]  

  • 19. Antipsychotic medication for childhood-onset schizophrenia.
    Kennedy E; Kumar A; Datta SS
    Schizophr Bull; 2007 Sep; 33(5):1082-3. PubMed ID: 17670793
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials.
    Correll CU; Maayan L; Kane J; Hert MD; Cohen D
    J Clin Psychiatry; 2016 Jun; 77(6):e746-56. PubMed ID: 27337425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.